4//SEC Filing
Sundaram Preethi 4
Accession 0001161697-25-000189
CIK 0001369568other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:00 PM ET
Size
7.0 KB
Accession
0001161697-25-000189
Insider Transaction Report
Form 4
Sundaram Preethi
Chief Strategy Officer
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-06-10$26.41/sh−2,324$61,377→ 42,681 total - Sale
Common Stock, par value $0.001 per share
2025-06-11$26.42/sh−1,600$42,272→ 41,081 total
Footnotes (3)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.49 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.48 per share.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001872422
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:00 PM ET
- Size
- 7.0 KB